Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/9190
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | K. Graydon, Elizabeth | - |
dc.contributor.author | M.W. Malloy, Allison | - |
dc.contributor.author | Machmach, Kawthar | - |
dc.date.accessioned | 2024-12-18T02:09:58Z | - |
dc.date.available | 2024-12-18T02:09:58Z | - |
dc.date.issued | 2023 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/9190 | - |
dc.description.abstract | This study tested the hypothesis that high frequencies of natural killer (NK) cells are protective against symptomatic SARS-CoV-2 infection. Samples were utilized from the COVID-19 Health Action Response for Marines study, a prospective, observational study of SARS-CoV-2 infection in which participants were enrolled prior to infection and then serially monitored for development of symptomatic or asymptomatic infection. Frequencies and phenotypes of NK cells (CD3 CD14 CD19 CD56+) were assessed by flow cytometry. Individuals that developed asymptomatic infections were found to have higher pre-infection frequencies of total NK cells compared to symptomatic individuals (10.61% [SD 4.5] vs 8.33% [SD 4.6], p = 0.011). Circulating total NK cells decreased over the course of infection, reaching a nadir at 4 weeks, while immature NK cells increased, a finding confirmed by multidimensional reduction analysis. These results indicate that NK cells likely play a key role in controlling the severity of clinical illness in individuals infected with SARS-CoV-2. | en_US |
dc.subject | NK cells Natural killer cells SARS-CoV-2 Asymptomatic Symptomatic | en_US |
dc.title | High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 4 2023 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
3- 100064.pdf | 3.13 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.